Navigation Links
Appointment of Dr. Ian Gilham as Chairman of the Board
Date:3/5/2013

LISBON, Portugal, March 5, 2013 /PRNewswire/ --

Biosurfit, a rapidly-growing company focused on the Point of Care medical diagnostic market, is pleased to announce today the appointment of Dr. Ian Gilham as Chairman of the Board.

Previously, Dr. Ian Gilham was Chief Executive Officer of Axis-Shield plc, the in-vitro diagnostics company acquired by Alere in November 2011 for £235M.  Whilst at Axis-Shield, Dr. Gilham held the position of Chief Operating Officer and became Chief Executive Officer in January 2008. Prior to its sale to Alere, Axis-Shield's revenues rose above £100M and the company issued a maiden dividend.  Before joining Axis-Shield, Dr. Gilham was VP Pharmacogenetics at GSK where he was responsible for the delivery of pharmacogentic tests, as well as novel diagnostic tests used in targeting GSK's medicines.  Prior to joining GSK, Dr. Gilham held international general management, marketing, business development and R&D positions with Abbott Laboratories, Celltech and Amersham, gaining wide expertise in the fields of pharmaceuticals and clinical diagnostics.

Commenting on his appointment, Dr. Ian Gilham , said: "I am delighted to join Biosurfit as Chairman of the Board. It is an incredibly exciting time for the company with new opportunities ahead and a chance to support an entrepreneurial team that have developed innovative and potentially game changing technologies into a great new product. Biosurfit has a tremendous potential in Point of Care Diagnostics with its spinit® instrument that is due to be launched in 2013. I look forward to working with the team to help Biosurfit in reaching its great ambitions."

João Garcia da Fonseca , Founder and CEO of Biosurfit, commented: "We are all delighted to have Ian join the team, particularly as we are preparing to launch our spinit® instrument in the Point of Care testing market. Ian is an experienced leader with an international track record in the research, development and commercialisation of diagnostic and pharmaceutical products. His wealth of experience and great knowledge of the IVD industry will be extremely valuable to Biosurfit."

About Biosurfit

Biosurfit is a Venture Capital backed diagnostics company founded in 2006. The company invented and developed breakthrough technologies that enable fast, precise and affordable blood analysis, aiming for the key parameters that doctors really want. These proprietary technologies are combined in the spinit® instrument, using a user-friendly reader and disposable disk cartridges for specific clinical conditions. The spinit® instrument uses only one drop of blood to deliver precise results within 10-15 minutes. Initial disposable cartridges to be launched in 2013 include CRP, Blood Count and an Inflammation Panel. It is planned that future tests will include diabetes and cardiac multi-parameter panels.

For more information, please contact:

João Garcia da Fonseca , CEO of Biosurfit, tel: +351-217500228

Mary-Jane Elliott or Claire Dickinson , M:Communications, tel: +44(0)20-7920-2345



'/>"/>
SOURCE Biosurfit
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online
2. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
3. American Oriental Bioengineering Announces Appointment of Audit Committee Chairman
4. Savient Pharmaceuticals Announces CEO Appointment and Reorganization Plan to Drive Long-Term Growth
5. OceanGate Inc. Expands Board of Directors with Two Key Appointments
6. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
7. ADVENTRX Announces Appointment Of Chief Medical Officer
8. Aragon Pharmaceuticals Announces Appointment of Faheem Hasnain as Independent Director
9. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
10. H. D. Smith Names Timothy Booth Corporate VP, Home Healthcare (HHC), In First-of-its-Kind Leadership Appointment
11. Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , May 5, 2016 Research ... PET Imaging in Top 5 EU Markets"  report to their ... This report provides information on the current Positron Emission Tomography ... European Markets (T5 EU), which includes France ... , Spain and the ...
(Date:5/4/2016)...  Compass Diversified Holdings (NYSE: CODI ) ... leading middle market businesses, announced today its consolidated operating ... First Quarter 2016 Highlights , Generated ... "Cash Flow") of $13.6 million for the first quarter ... million for the first quarter of 2016; , ...
(Date:5/4/2016)... Yissum Research Development Company of the ... had signed an exclusive world-wide licensing and research agreement ... degradation and immunomodulatory drugs for cancer and immune dysfunction, ... first-in-class therapy for hematologic and solid malignancies. Financial terms ... novel technology was developed by Yinon Ben-Neriah , ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Vitenas Cosmetic Surgery has been ... presented by the American Institute of Architects and the Academy of Architecture for Health. ... Perkins+Will and Harrell Architects, opened to patients in October of 2014. ...
(Date:5/5/2016)... ... 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial Plastic Surgery, LLC ... Stong is double board certified and the only facial plastic surgeon in Atlanta to ... Non-surgical therapies such as stem cells can be used to provide stabilization to hair ...
(Date:5/5/2016)... ... May 05, 2016 , ... In honor of National Nurses Week 2016, ... the United States to thank a nurse who's made a difference in their life. ... the American Red Cross of San Diego/Imperial Counties (up to $10,000) every time someone ...
(Date:5/5/2016)... Boston, MA (PRWEB) , ... May 05, 2016 , ... ... stress becomes a constant presence, it can weaken the immune system and increase inflammation, ... Ami B. Bhatt, director of the adult congenital heart disease program at Harvard-affiliated Massachusetts ...
(Date:5/5/2016)... PLAINSBORO, N.J. (PRWEB) , ... May 05, 2016 , ... ... on patients with cancer, today announced a new collaboration with Imerman Angels ... of cancer anywhere in the world. , “Imerman Angels provides an emotional lifeline to ...
Breaking Medicine News(10 mins):